Clinical Study
A Study of Patients with Primary Mediastinal Germ Cell Tumors Treated Using Multimodal Therapy
Table 2
Clinical characteristics, treatments, and outcomes of the six patients with primary mediastinal germ cell tumors.
| | | Age | Sex | BMI | Metastases | Histopathology | Preceding chemotherapy (courses) | Preoperative chemotherapy (courses) | Recurrence | Salvage chemotherapy (courses) | Follow-up (months) |
| | Preceding surgery | | | | | | | | | | | | Case 1 | 27 | Male | 21.0 | No | Seminoma | — | BEP (1)/EP (2) | Lung metastasis | VeIP (2) | 36 | | Case 2 | 25 | Male | 23.1 | No | Yolk sac | — | BEP (1)/EP (3) | No | No | 36 | | Case 3 | 19 | Male | 16.6 | No | Seminoma | — | BEP (1)/EP (2) | No | No | 29 | | Preceding chemotherapy | | | | | | | | | | | | Case 4 | 27 | Male | 19.1 | Supraclavicular lymph node | Seminoma | BEP (1)/EP (3)/VeIP (2) | — | No | No | 84 | | Case 5 | 22 | Male | 41.8 | No | Yolk sac | BEP (3)/EP (2) | — | No | No | 16 | | Case 6 | 25 | Male | 24.9 | Lung | Choriocarcinoma | BEP (3)/EP (1) | — | No | No | 8 |
|
|
BEP: bleomycin, etoposide, and cisplatin; BMI: body mass index; EP: etoposide and cisplatin; VeIP: vinblastine, ifosfamide, and cisplatin.
|
